NYXH

Nyxoah

8.15 USD
+0.15
1.88%
Updated Dec 3, 9:30 AM EST
1 day
1.88%
5 days
0.12%
1 month
-13.67%
3 months
4.49%
6 months
-5.23%
Year to date
72.30%
1 year
66.33%
5 years
-72.93%
10 years
-72.93%
0
Funds holding %
of 6,780 funds
0
Analysts bullish %
of 3 analysts

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

33% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 3

33% more capital invested

Capital invested by funds: $29.4M [Q2] → $39.1M (+$9.75M) [Q3]

0.37% less ownership

Funds ownership: 12.32% [Q2] → 11.95% (-0.37%) [Q3]

5% less funds holding

Funds holding: 21 [Q2] → 20 (-1) [Q3]

20% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 5

Research analyst outlook

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$16
96%
upside
Avg. target
$17
109%
upside
High target
$18
121%
upside

3 analyst ratings

positive
100%
neutral
0%
negative
0%
Cantor Fitzgerald
Ross Osborn
58% 1-year accuracy
21 / 36 met price target
96%upside
$16
Overweight
Reiterated
5 Nov 2024
HC Wainwright & Co.
Edward White
28% 1-year accuracy
35 / 124 met price target
109%upside
$17
Buy
Maintained
11 Oct 2024
HC Wainwright & Co.
Edward White
28% 1-year accuracy
35 / 124 met price target
121%upside
$18
Buy
Reiterated
30 Sept 2024

Financial journalist opinion

Based on 6 articles about NYXH published over the past 30 days

Neutral
GlobeNewsWire
1 week ago
Nyxoah to Participate in the Piper Sandler 36th Annual Healthcare Conference
Nyxoah to Participate in the Piper Sandler 36 th Annual Healthcare Conference
Nyxoah to Participate in the Piper Sandler 36th Annual Healthcare Conference
Neutral
GlobeNewsWire
2 weeks ago
Invitation to attend the special shareholders' meeting of the Company to be held on December 19, 2024
REGULATED INFORMATION November 19, 2024, 7:00am CET / 1:00am ET NYXOAH SA (Euronext Brussels/Nasdaq: NYXH) Rue Edouard Belin 12, 1435 Mont-Saint-Guibert, Belgium(hereinafter the “Company”) Invitation to attend the special shareholders' meeting of the Company to be held on December 19, 2024 The board of directors of the Company is pleased to invite its securities holders to attend the special shareholders' meeting of the Company, to be held on Thursday, December 19, 2024 at 3:00 p.m. CET at the Company's seat, or at such other place as will be indicated prior to such time.
Invitation to attend the special shareholders' meeting of the Company to be held on December 19, 2024
Neutral
GlobeNewsWire
2 weeks ago
Publication relating to transparency notifications
REGULATED INFORMATION Publication relating to transparency notifications Mont-Saint-Guibert (Belgium), November 18, 2024 , 10:30 pm CET / 4:30 pm ET – In accordance with article 14 of the Act of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) announces that it received a transparency notification as detailed below. On November 15, 2024, Nyxoah received a transparency notification from ResMed Inc. following the passive crossing of a threshold.
Publication relating to transparency notifications
Neutral
Seeking Alpha
3 weeks ago
Nyxoah S.A. (NYXH) Q3 2024 Earnings Call Transcript
Nyxoah S.A. (NASDAQ:NYXH ) Q3 2024 Earnings Conference Call November 6, 2024 4:30 PM ET Company Participants Mikaela Kirkwood - Corporate Communications and IR Manager Olivier Taelman - CEO Loic Moreau - CFO Conference Call Participants Adam Maeder - Piper Sandler Joe Federico - Stifel Suraj Kalia - Oppenheimer Ross Osborn - Cantor Fitzgerald David Rescott - Baird Operator Good day.
Nyxoah S.A. (NYXH) Q3 2024 Earnings Call Transcript
Negative
Zacks Investment Research
3 weeks ago
Nyxoah SA (NYXH) Reports Q3 Loss, Tops Revenue Estimates
Nyxoah SA (NYXH) came out with a quarterly loss of $0.68 per share versus the Zacks Consensus Estimate of a loss of $0.46. This compares to loss of $0.29 per share a year ago.
Nyxoah SA (NYXH) Reports Q3 Loss, Tops Revenue Estimates
Neutral
GlobeNewsWire
4 weeks ago
Nyxoah Appoints John Landry as Chief Financial Officer
Nyxoah Appoints John Landry as Chief Financial Officer Current CFO, Loïc Moreau, to Transition into Role of President International Mont-Saint-Guibert, Belgium – November 4, 2024, 10:45pm CET / 4:45pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company that develops breakthrough treatment alternatives for Obstructive Sleep Apnea (OSA) through neuromodulation, today announced the appointment of John Landry as Chief Financial Officer (CFO), effective November 4, 2024. This strategic appointment, in combination with the recent move to the United States of CEO Olivier Taelman, strengthens the Company's focus on the U.S. market.
Nyxoah Appoints John Landry as Chief Financial Officer
Positive
Zacks Investment Research
1 month ago
Nyxoah SA (NYXH) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
Nyxoah (NYXH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Nyxoah SA (NYXH) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
Neutral
GlobeNewsWire
1 month ago
Publication relating to transparency notifications
REGULATED INFORMATION Publication relating to transparency notifications Mont-Saint-Guibert (Belgium), October 25, 2024 , 10:30 pm CET / 4:30 pm ET – In accordance with article 14 of the Act of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) announces that it received a transparency notification as detailed below. Vestal Point Capital On October 23, 2024, Nyxoah received a transparency notification from Vestal Point Capital following an acquisition or disposal of voting securities or voting rights.
Publication relating to transparency notifications
Neutral
GlobeNewsWire
1 month ago
Nyxoah to Release Third Quarter 2024 Financial Results on November 6, 2024
Nyxoah to Release Third Quarter 2024 Financial Results on November 6, 2024 Mont-Saint-Guibert, Belgium – October 22, 2024, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company will release financial results for the third quarter 2024 on Wednesday, November 6, 2024, after market close. Company management will host a conference call to discuss financial results that day beginning at 10:30pm CET / 4:30pm ET.
Nyxoah to Release Third Quarter 2024 Financial Results on November 6, 2024
Neutral
GlobeNewsWire
1 month ago
Publication relating to transparency notifications
REGULATED INFORMATION Publication relating to transparency notifications Mont-Saint-Guibert (Belgium), October 15, 2024 , 10:30 pm CET / 4:30 pm ET – In accordance with article 14 of the Act of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) announces that it received three transparency notifications as detailed below. Jürgen Hambrecht On October 15, 2024, Nyxoah received a transparency notification from Jürgen Hambrecht and Jürgen Hambrecht's controlled undertaking JH Capital GmbH following an acquisition or disposal of voting securities or voting rights.
Publication relating to transparency notifications
Charts implemented using Lightweight Charts™